Hospira has emerged as a bidder for Danone's medical-nutrition unit in a deal that could be worth about $5 billion and mark the latest in a flurry of so-called inversion deals.
from WSJ.com: US Business http://ift.tt/1oyaILj
via IFTTT
from WSJ.com: US Business http://ift.tt/1oyaILj
via IFTTT
No comments:
Post a Comment